The expanding demand for controlled immunological research and therapeutic creation has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are Helicobacter Pylori(HP) antigen frequently produced using diverse expression platforms, including prokaryotic hosts,